Francesca Piaggio
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Therapeutic vaccination for glioblastoma elicited by retargeted oncolytic herpes virus.
Journal: Journal for immunotherapy of cancer
Published: December 19, 2025
Early clonal extinction in glioblastoma progression revealed by genetic barcoding.
Journal: Cancer cell
Published: March 03, 2022
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2022
A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 01, 2015
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion.
Journal: Biomaterials
Published: April 22, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 20, 2015
New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
Journal: Oncotarget
Published: March 10, 2015
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 11, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026